WKA
PFE icon

Wilson Kemp & Associates’s Pfizer PFE Stock Holding History

Wilson Kemp & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$749K Sell
26,696
-17,596
-40% -$494K 6.83% 2
2014
Q2 		$1.25M Sell
44,292
-16,031
-27% -$457K 4.47% 2
2014
Q1 		$1.84M Sell
60,323
-20,817
-26% -$621K 4.78% 2
2013
Q4 		$2.36M Buy
81,140
+8,768
+12% +$255K 4.53% 3
2013
Q3 		$1.97M Sell
72,372
-49,444
-41% -$1.35M 4.34% 4
2013
Q2 		$3.24M Buy
+121,816
New +$3.37M 3.1% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wilson Kemp & Associates's PFE Position: Q3 2014 in Review

Wilson Kemp & Associates reduced its Pfizer (PFE) stake by 40% in Q3 2014, selling an estimated $494K and leaving 26,696 shares worth $749K. The position accounts for 6.83% of the portfolio, ranked #2.

Wilson Kemp & Associates first reported a position in PFE in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.24M in Q2 2013. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Wilson Kemp & Associates held 26,696 shares of Pfizer worth $749K as of Q3 2014.
  • Wilson Kemp & Associates sold 17,596 Pfizer shares in Q3 2014, an estimated $494K.
  • Pfizer made up 6.83% of Wilson Kemp & Associates's portfolio in Q3 2014, its #2 holding.
  • Wilson Kemp & Associates first reported a position in Pfizer in Q2 2013 and has held it in 6 quarters since.
  • Wilson Kemp & Associates's Pfizer position peaked at $3.24M in Q2 2013.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Wilson Kemp & Associates's 13F filing for Q3 2014, filed 20 Oct 2014.